Nothing Special   »   [go: up one dir, main page]

DE60025241D1 - HäMOPOIETINREZEPTOR-PROTEIN, NR12 - Google Patents

HäMOPOIETINREZEPTOR-PROTEIN, NR12

Info

Publication number
DE60025241D1
DE60025241D1 DE60025241T DE60025241T DE60025241D1 DE 60025241 D1 DE60025241 D1 DE 60025241D1 DE 60025241 T DE60025241 T DE 60025241T DE 60025241 T DE60025241 T DE 60025241T DE 60025241 D1 DE60025241 D1 DE 60025241D1
Authority
DE
Germany
Prior art keywords
receptor protein
hemopoietin receptor
hemopoietin
protein
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025241T
Other languages
English (en)
Other versions
DE60025241T2 (de
Inventor
Masatsugu Maeda
Noriko Yaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DE60025241D1 publication Critical patent/DE60025241D1/de
Application granted granted Critical
Publication of DE60025241T2 publication Critical patent/DE60025241T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60025241T 1999-09-27 2000-09-27 HäMOPOIETINREZEPTOR-PROTEIN, NR12 Expired - Lifetime DE60025241T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP27335899 1999-09-27
JP27335899 1999-09-27
JP2000240397 2000-08-03
JP2000240397 2000-08-03
PCT/JP2000/006654 WO2001023556A1 (fr) 1999-09-27 2000-09-27 Nouvelle proteine receptrice d'hemopoietine (nr12)

Publications (2)

Publication Number Publication Date
DE60025241D1 true DE60025241D1 (de) 2006-02-02
DE60025241T2 DE60025241T2 (de) 2007-01-11

Family

ID=26550628

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025241T Expired - Lifetime DE60025241T2 (de) 1999-09-27 2000-09-27 HäMOPOIETINREZEPTOR-PROTEIN, NR12

Country Status (6)

Country Link
US (9) US7045595B2 (de)
EP (1) EP1221482B1 (de)
AU (1) AU7445900A (de)
DE (1) DE60025241T2 (de)
ES (1) ES2254224T3 (de)
WO (1) WO2001023556A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2258849A1 (de) * 1999-06-01 2010-12-08 Schering Corporation Säugetier-Rezeptorproteine; ähnliche Reagentien und Methoden
PT1188830E (pt) 1999-06-02 2010-04-09 Chugai Pharmaceutical Co Ltd Nova proteína nr10 receptora da hemopoietina
AU2007202362B2 (en) * 1999-09-03 2011-06-23 Merck Sharp & Dohme Corp. Mammalian receptor proteins; related reagents and methods
AU7445900A (en) * 1999-09-27 2001-04-30 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor protein, nr12
DE60134136D1 (de) 2000-05-10 2008-07-03 Schering Corp Zytokinrezeptoruntereinheit-proteine aus säugetieren, damit zusammenhängende reagenzien und methoden
US7422743B2 (en) 2000-05-10 2008-09-09 Schering Corporation Mammalian receptor protein DCRS5;methods of treatment
WO2002029060A2 (en) * 2000-10-06 2002-04-11 Immunex Corporation Hematopoietin receptors hpr1 and hpr2
WO2004042009A2 (en) 2002-10-30 2004-05-21 Genentech, Inc. Inhibition of il-17 production
WO2004101611A2 (en) * 2003-05-12 2004-11-25 Affymax, Inc. Peptides that bind to the erythropoietin receptor
US7919118B2 (en) 2003-05-12 2011-04-05 Affymax, Inc. Spacer moiety for poly (ethylene glycol) modified peptide based compounds
CA2525568C (en) * 2003-05-12 2017-07-25 Affymax, Inc. Novel peptides that bind to the erythropoietin receptor
AU2004238869B2 (en) * 2003-05-12 2009-06-25 Affymax, Inc. Novel poly(ethylene glycol) modified compounds and uses thereof
WO2006062685A2 (en) * 2004-11-11 2006-06-15 Affymax, Inc. Novel peptides that bind to the erythropoietin receptor
AU2005310189A1 (en) * 2004-11-11 2006-06-08 Affymax, Inc. Novel peptides that bind to the erythropoietin receptor
US20060257935A1 (en) * 2005-04-26 2006-11-16 Ajinomoto Co., Inc. Hematopoietic factor production promoter
US7550433B2 (en) * 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US8324159B2 (en) * 2005-06-03 2012-12-04 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US7919461B2 (en) 2005-06-03 2011-04-05 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
UA100116C2 (ru) 2006-06-08 2012-11-26 Чугей Сейяку Кабусики Кайся Профилактика или лечение воспалительного заболевания
CA2676820A1 (en) * 2007-01-31 2008-08-07 Affymax, Inc. Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
US8119133B2 (en) 2007-02-28 2012-02-21 Schering Corporation Engineered anti-IL-23R antibodies
NZ579297A (en) 2007-02-28 2012-03-30 Schering Corp Combination therapy comprising an il-23 antagonist and a cytokine antagonist for treatment of immune disorders
JP2011501941A (ja) * 2007-07-06 2011-01-20 バロリゼイション エイチエスジェイ， ソシエテ アン コマンディテ Ｉｌ−２３レセプターのアンタゴニストおよびその使用
BRPI0821145B8 (pt) 2007-12-05 2021-05-25 Chugai Pharmaceutical Co Ltd uso de um anticorpo anti-nr10 como agente preventivo ou terapêutico para prurido
MX355256B (es) * 2008-05-05 2018-04-11 Novimmune Sa Anticuerpos anti-il-17a/il-17f de reactividad cruzada y métodos de uso de los mismos.
US20110158992A1 (en) * 2008-08-27 2011-06-30 Schering Corporation Engineered Anti-IL-23R Antibodies
SG175276A1 (en) * 2009-05-05 2011-11-28 Novimmune Sa Anti-il-17f antibodies and methods of use thereof
CN102206667B (zh) * 2011-04-18 2012-10-10 中国药科大学 重组质粒pET32a-hIL-23R-CHR及其构建表达
CA2980992C (en) 2015-04-14 2024-01-23 Akihisa Kaneko Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient
EP3232000A1 (de) 2016-04-15 2017-10-18 Siemens Aktiengesellschaft Plattform einer laufschaufel mit filmkühlungsöffnungen an der plattform und zugehörige strömugsmaschine
KR102416078B1 (ko) 2019-11-20 2022-07-01 추가이 세이야쿠 가부시키가이샤 항체 함유 제제

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732863A (en) * 1984-12-31 1988-03-22 University Of New Mexico PEG-modified antibody with reduced affinity for cell surface Fc receptors
JP2898064B2 (ja) 1989-08-03 1999-05-31 忠三 岸本 ヒトｇｐ１３０蛋白質
GB9016440D0 (en) 1990-07-26 1990-09-12 Elopak Systems A laminate
US5783672A (en) 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M
AUPN481295A0 (en) * 1995-08-16 1995-09-07 Medvet Science Pty. Ltd. Agonists of haemopoietic growth factors
AUPN564195A0 (en) * 1995-09-26 1995-10-19 Walter And Eliza Hall Institute Of Medical Research, The A novel haemopoietin receptor and genetic sequences encoding same
CA2238080C (en) * 1995-10-23 2012-03-13 Amrad Operations Pty. Ltd. A novel haemopoietin receptor and genetic sequences encoding same
US6642360B2 (en) * 1997-12-03 2003-11-04 Genentech, Inc. Secreted polypeptides that stimulate release of proteoglycans from cartilage
US6747137B1 (en) * 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
WO1999067290A1 (fr) 1998-06-24 1999-12-29 Chugai Research Institute For Molecular Medicine, Inc. Nouvelles proteines receptrices d'hemopoïetine
US20030082734A1 (en) * 1999-06-01 2003-05-01 Dowling Lynette M. Mammalian receptor proteins; related reagents and methods
EP2258849A1 (de) 1999-06-01 2010-12-08 Schering Corporation Säugetier-Rezeptorproteine; ähnliche Reagentien und Methoden
PT1188830E (pt) 1999-06-02 2010-04-09 Chugai Pharmaceutical Co Ltd Nova proteína nr10 receptora da hemopoietina
AU7445900A (en) * 1999-09-27 2001-04-30 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor protein, nr12
DE60134136D1 (de) * 2000-05-10 2008-07-03 Schering Corp Zytokinrezeptoruntereinheit-proteine aus säugetieren, damit zusammenhängende reagenzien und methoden
CA2412239C (en) 2000-06-26 2013-05-28 Zymogenetics, Inc. Cytokine receptor zcytor17
WO2002029060A2 (en) 2000-10-06 2002-04-11 Immunex Corporation Hematopoietin receptors hpr1 and hpr2
WO2002077230A1 (fr) 2001-03-26 2002-10-03 Chugai Seiyaku Kabushiki Kaisha Variants d'epissage nr10
ES2377188T3 (es) 2002-01-18 2012-03-23 Zymogenetics, Inc. Nuevo ligando de citocina ZCYTOR17
EP2840089A1 (de) 2002-01-18 2015-02-25 ZymoGenetics, Inc. Zytokinrezeptor Zyctor17-Multimere
EP2110434A1 (de) 2002-02-25 2009-10-21 Genentech, Inc. Typ-1 Cytokine Rezeptor GLM-R
CN100563709C (zh) * 2002-05-01 2009-12-02 舍林股份公司 作为抗凝剂的新的靶向组织因子的抗体
US7579000B2 (en) * 2002-05-01 2009-08-25 Bayer Schering Pharma Ag Tissue factor targeted antibodies as anticoagulants
EP1671642A1 (de) 2004-12-15 2006-06-21 Universite D'angers Zusammensetzungen mit (Ant)agonisten von Oncostatin M (OSM), IL-31 und IFN-gamma zur Modulierung der Migration und Funktion von Keratinozyten via einen Rezeptor welcher OSMRbeta als Untereinheit enthält, und entprechende Anwendungen
EP1848737B1 (de) 2005-01-28 2016-05-18 ZymoGenetics, Inc. Homogene präparate von il-31
CA2594490A1 (en) 2005-02-14 2006-08-24 Zymogenetics Inc. Methods of treating skin disorders using an il-31ra antagonist
WO2006088955A2 (en) 2005-02-14 2006-08-24 Zymogenetics, Inc. Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
JP5065253B2 (ja) 2005-05-06 2012-10-31 ザイモジェネティクス， インコーポレイテッド Ｉｌ−３１モノクローナル抗体とその使用法
EP1991581A2 (de) 2006-01-10 2008-11-19 Zymogenetics, Inc. Verfahren zur behandlung von schmerzen und entzündungen in einem nervengewebe mithilfe von il-3-antagonisten
UA100116C2 (ru) * 2006-06-08 2012-11-26 Чугей Сейяку Кабусики Кайся Профилактика или лечение воспалительного заболевания
TWI434703B (zh) * 2007-05-14 2014-04-21 Kao Corp 皮膚洗淨劑組成物
JP5132292B2 (ja) * 2007-12-07 2013-01-30 キヤノン株式会社 情報処理装置および情報処理方法

Also Published As

Publication number Publication date
US20070203328A1 (en) 2007-08-30
US7893201B2 (en) 2011-02-22
AU7445900A (en) 2001-04-30
US20090105458A1 (en) 2009-04-23
EP1221482B1 (de) 2005-12-28
US7045595B2 (en) 2006-05-16
WO2001023556A1 (fr) 2001-04-05
US20090029484A1 (en) 2009-01-29
EP1221482A1 (de) 2002-07-10
US20090023660A1 (en) 2009-01-22
US20090105457A1 (en) 2009-04-23
EP1221482A4 (de) 2003-03-26
ES2254224T3 (es) 2006-06-16
US20060106201A1 (en) 2006-05-18
US20090105459A1 (en) 2009-04-23
DE60025241T2 (de) 2007-01-11
US7893205B2 (en) 2011-02-22
US20090111972A1 (en) 2009-04-30
US20030009018A1 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
DE60025241D1 (de) HäMOPOIETINREZEPTOR-PROTEIN, NR12
DE50007846D1 (de) Dreschkorb
DE60001530T2 (de) Verbinder
DE60020922D1 (de) Verbinder
MA25499A1 (fr) Contacteur-disjoncteur.
MA26849A1 (fr) 4-pyridinyle-n-acyl-l-phenylalanines.
DE60008069D1 (de) Verbinder
DE60019059D1 (de) Verbinder
DE60001032D1 (de) Verbinder
NO20013997D0 (no) Reseptoranalyse
DE60043606D1 (de) Verbinder
DE60015473D1 (de) Verbinder
IT1310460B1 (it) Dispositivo gommatore .
DE60027520D1 (de) Verbinder
DE60024400D1 (de) Empfangsgerät
DE60001783D1 (de) Verbinder
DE60026234D1 (de) Verbinder
DE60029755D1 (de) Congawandschutz.
ATE264301T1 (de) Muscarin-antagonisten
DE60014496D1 (de) Verbinder
DE60017062D1 (de) Verbinder
DE60012162D1 (de) Verbinder
NO20021295L (no) Nikotinsyreacetylcholin-reseptor
ITBO990358A0 (it) Elettromandrino .
DE60009806T2 (de) Verbinder

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication of lapse of patent is to be deleted
8364 No opposition during term of opposition